Vezzosi D - Search Results

1

Impact pronostique de la prise en charge chirurgicale dans le corticosurrénalome malin à propos d'une série de 23 cas.

Nasr EB, Gryn A, Gas J, Crenn G, Thoulouzan M, Almont T, Roumiguie M, Beauval J, Bennet A, Vezzosi D, Carron P, Rischmann P, Soulie M, Huyghe E. Nasr EB, et al. Among authors: vezzosi d. Prog Urol. 2014 Nov;24(13):884-5. doi: 10.1016/j.purol.2014.08.219. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461744 French. No abstract available.

2

Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism.

Vezzosi D, Bennet A, Fauvel J, Boulanger C, Tazi O, Louvet JP, Caron P. Vezzosi D, et al. Eur J Endocrinol. 2003 Nov;149(5):413-9. doi: 10.1530/eje.0.1490413. Eur J Endocrinol. 2003. PMID: 14585087 Clinical Trial.

3

Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide.

Boulanger C, Vezzosi D, Bennet A, Lorenzini F, Fauvel J, Caron P. Boulanger C, et al. Among authors: vezzosi d. J Endocrinol Invest. 2004 May;27(5):465-70. doi: 10.1007/BF03345293. J Endocrinol Invest. 2004. PMID: 15279081

4

Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.

Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, Buscail L, Susini C, Caron P. Vezzosi D, et al. Eur J Endocrinol. 2005 May;152(5):757-67. doi: 10.1530/eje.1.01901. Eur J Endocrinol. 2005. PMID: 15879362

5

Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.

Benit A, Allard J, Rimailho J, Fauvel J, Escourrou G, Vezzosi D, Donadille F, Bennet A, Caron P. Benit A, et al. Among authors: vezzosi d. J Endocrinol Invest. 2006 May;29(5):443-9. doi: 10.1007/BF03344128. J Endocrinol Invest. 2006. PMID: 16794368

6

Recent advances in treatment of medullary thyroid carcinoma.

Vezzosi D, Bennet A, Caron P. Vezzosi D, et al. Ann Endocrinol (Paris). 2007 Jun;68(2-3):147-53. doi: 10.1016/j.ando.2006.11.004. Epub 2007 Mar 27. Ann Endocrinol (Paris). 2007. PMID: 17391636 Review.

7

[Non-deferential male contraception: review of the literature].

Huyghe E, Nohra J, Vezzosi D, Bennet A, Caron P, Mieusset R, Bujan L, Plante P. Huyghe E, et al. Among authors: vezzosi d. Prog Urol. 2007 Apr;17(2):156-64. doi: 10.1016/s1166-7087(07)92254-x. Prog Urol. 2007. PMID: 17489310 Review. French.

8

Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa.

Maiza JC, Vezzosi D, Matta M, Donadille F, Loubes-Lacroix F, Cournot M, Bennet A, Caron P. Maiza JC, et al. Among authors: vezzosi d. Clin Endocrinol (Oxf). 2007 Aug;67(2):282-9. doi: 10.1111/j.1365-2265.2007.02878.x. Epub 2007 May 24. Clin Endocrinol (Oxf). 2007. PMID: 17524029 Free PMC article. Clinical Trial.

9

Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.

Vezzosi D, Bennet A, Fauvel J, Caron P. Vezzosi D, et al. Eur J Endocrinol. 2007 Jul;157(1):75-83. doi: 10.1530/EJE-07-0109. Eur J Endocrinol. 2007. PMID: 17609405 Clinical Trial.

10

Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.

Vezzosi D, Bennet A, Courbon F, Caron P. Vezzosi D, et al. Clin Endocrinol (Oxf). 2008 Jun;68(6):904-11. doi: 10.1111/j.1365-2265.2007.03136.x. Epub 2007 Nov 19. Clin Endocrinol (Oxf). 2008. PMID: 18031316 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page